Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a developer of innovative RNA-based therapeutics, announced today that management is scheduled to present a company overview at the following investor conferences in November. Chris Garabedian, Sarepta’s president and chief executive officer, will be the presenter.
Help employers find you! Check out all the jobs and post your resume.
